Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY

v3.3.1.900
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Balance at Dec. 31, 2013 $ (13,038,293) $ 9,600 $ 23,244,639 $ (36,292,532)
Balance (in shares) at Dec. 31, 2013   9,600,453    
Stock Issues for Services 564,874   $ 189 564,685  
Stock Issues for Services (in shares)     188,574    
Conversion of Note Payable and Interest 373,159   $ 278 372,881  
Conversion of Note Payable and Interest (in shares)     277,778    
Exercise of Warrants 2,682,695   $ 1,229 2,681,466  
Exercise of Warrants (in shares)     1,228,582    
Stock Compensation Expense 260,746     260,746  
Reclass Fair Value of Warrant Derivative Liability upon Exercise 2,127,405     2,127,405  
Reclass Fair Value of Derivative Liability upon note conversion 500,261     $ 500,261  
Net Loss (7,868,858) (7,868,858)
Balance at Dec. 31, 2014 (14,398,011) $ 11,296 $ 29,752,083 (44,161,390)
Balance (in shares) at Dec. 31, 2014   11,295,387    
Stock Issues for Services 676,665   $ 121 676,544  
Stock Issues for Services (in shares)     120,837    
Conversion of Note Payable and Interest 472,500   $ 210 472,290  
Conversion of Note Payable and Interest (in shares)     210,000    
Exercise of Warrants 1,272,626   $ 4,128 1,268,498  
Exercise of Warrants (in shares)     4,128,271    
Warrants Issued for Services 260,373     260,373  
Stock Compensation Expense 568,848     568,848  
Common Stock Awards to Officers, Directors and Law Firm 1,669,700   $ 325 1,669,375  
Common Stock Awards to Officers, Directors and Law Firm (in Shares)     325,000    
Proceeds from Preferred Stock Offering 24,813,000 $ 50   24,812,950  
Proceeds from Preferred Stock Offering (in Shares)   49,626      
Direct costs of preferred stock Offering (214,169)     (214,169)  
Reclass Fair Value of Warrant Derivative Liability Upon Waiver of Certain Anti-Dilutive Provisions 2,806,942     2,806,942  
Reclass Fair Value of Note Derivative Liability Upon Waiver of Certain Anti-Dilutive Provisions $ 8,736,412     8,736,412  
Exercise of Stock Options   $ 8 (8)  
Exercise of Stock Options (in shares)     8,456    
Reclass Fair Value of Warrant Derivative Liability upon Exercise $ 2,855,463     2,855,463  
Net Loss (13,427,478)       (13,427,478)
Balance at Dec. 31, 2015 $ 16,092,871 $ 50 $ 16,088 $ 73,665,601 $ (57,588,868)
Balance (in shares) at Dec. 31, 2015   49,626 16,087,951